Key points are not available for this paper at this time.
The intervention resulted in a significant decrease in HbA1c, without increasing the prevalence of hypoglycemia in patients with initial HbA1c >8.0% (63.9 mmol/mol).
Klee et al. (Wed,) studied this question.